These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35815891)

  • 1. Identifying Persistent Opioid Use After Surgery: The Reliability of Pharmacy Dispensation Databases.
    Fernandez AC; Bohnert A; Gunaseelan V; Motamed M; Waljee JF; Brummett CM
    Ann Surg; 2023 Jul; 278(1):e20-e26. PubMed ID: 35815891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Doctor and pharmacy shopping": A fading signal for prescription opioid use monitoring?
    Delcher C; Harris DR; Park C; Strickler GK; Talbert J; Freeman PR
    Drug Alcohol Depend; 2021 Apr; 221():108618. PubMed ID: 33677354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concordance of opioid exposure in all-payer claims databases with prescription drug monitoring program database using Arkansas as a case example.
    Mahashabde RV; Shrikhande MA; Han X; Martin BC; ElHassan NO; Hayes CJ
    Health Serv Res; 2023 Aug; 58(4):938-947. PubMed ID: 36519709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.
    Hawk K; D'Onofrio G; Fiellin DA; Chawarski MC; O'Connor PG; Owens PH; Pantalon MV; Bernstein SL
    Acad Emerg Med; 2018 May; 25(5):508-516. PubMed ID: 29165853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Postoperative Opioid Prescriptions Before and After Implementation of a Mandatory Prescription Drug Monitoring Program.
    Shenoy R; Wagner Z; Kirkegaard A; Romanelli RJ; Mudiganti S; Mariano L; Martinez M; Zanocco K; Watkins KE
    JAMA Health Forum; 2021 Oct; 2(10):e212924. PubMed ID: 35977161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usability of the Massachusetts Prescription Drug Monitoring Program in the Emergency Department: A Mixed-methods Study.
    Poon SJ; Greenwood-Ericksen MB; Gish RE; Neri PM; Takhar SS; Weiner SG; Schuur JD; Landman AB
    Acad Emerg Med; 2016 Apr; 23(4):406-14. PubMed ID: 26806310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
    Manders L; Abd-Elsayed A
    Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of trends in opioid dispensing patterns between Medicaid pharmacy claims and prescription drug monitoring program data.
    El Ibrahimi S; Hallvik S; Johnston K; Leichtling G; Choo E; Hartung DM
    Pharmacoepidemiol Drug Saf; 2020 Sep; 29(9):1168-1174. PubMed ID: 32939909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Query mandates in prescription drug monitoring programs reduce opioid use among commercially insured patients with cancer.
    Le TT; Fleming SP; Kuzucan A; Dizik A; Simoni-Wastila L
    J Am Pharm Assoc (2003); 2022; 62(1):363-369. PubMed ID: 34246576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis.
    Picco L; Xia T; Bell JS; Pearce C; Buchbinder R; Lubman DI; Nielsen S
    Drug Alcohol Rev; 2023 Nov; 42(7):1639-1646. PubMed ID: 37798947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.
    Martins SS; Ponicki W; Smith N; Rivera-Aguirre A; Davis CS; Fink DS; Castillo-Carniglia A; Henry SG; Marshall BDL; Gruenewald P; Cerdá M
    Int J Drug Policy; 2019 Dec; 74():174-180. PubMed ID: 31627159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System.
    Suffoletto B; Lynch M; Pacella CB; Yealy DM; Callaway CW
    J Pain; 2018 Apr; 19(4):430-438. PubMed ID: 29241835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Prescription Drug Monitoring Program Use Mandate and Opioid Prescribing and Patient-Reported Outcomes After Surgery.
    Chua KP; Nguyen TD; Brummett CM; Bohnert AS; Gunaseelan V; Englesbe MJ; Lee S; Waljee JF
    Ann Surg; 2024 May; ():. PubMed ID: 38716667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
    Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
    BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescription drug monitoring programs: Assessing the association between "best practices" and opioid use in Medicare.
    Moyo P; Simoni-Wastila L; Griffin BA; Harrington D; Alexander GC; Palumbo F; Onukwugha E
    Health Serv Res; 2019 Oct; 54(5):1045-1054. PubMed ID: 31372990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
    Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
    Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rates of New Persistent Opioid Use After Vaginal or Cesarean Birth Among US Women.
    Peahl AF; Dalton VK; Montgomery JR; Lai YL; Hu HM; Waljee JF
    JAMA Netw Open; 2019 Jul; 2(7):e197863. PubMed ID: 31348508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
    Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
    J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Evaluation of State Policy Interventions Targeting the US Opioid Epidemic, 2007-2018.
    Lee B; Zhao W; Yang KC; Ahn YY; Perry BL
    JAMA Netw Open; 2021 Feb; 4(2):e2036687. PubMed ID: 33576816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.